Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Puhr

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Endocrinology|September 10, 2024
MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate CancerChiara Andolfi, Caterina Bartolini, Elisa Morales, et al.
Journal of Medicinal Chemistry|December 18, 2024
Eradication of Therapy-Resistant Cancer Stem Cells by Novel Telmisartan DerivativesAnna M Schoepf, Maximilian Gebhart, Martin Federspiel, et al.
Frontiers in Oncology|October 30, 2025
Anti-neoplastic effects of the antipsychotic drug penfluridol in preclinical prostate cancer modelsArjanneke F van de Merbel, Maaike H van der Mark, Tilly Aalders, et al.
The American Journal of Pathology|December 7, 2006
Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancerIlaria Bellezza, Hannes Neuwirt, Constanze Nemes, et al.
International Journal of Molecular Sciences|June 6, 2013
Enhanced inhibition of prostate tumor growth by dual targeting the androgen receptor and the regulatory subunit type iα of protein kinase a in vivoIris E Eder, Martina Egger, Hannes Neuwirt, et al.
Journal of Translational Medicine|January 18, 2024
New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor SymposiumSherif Mehralivand, Christian Thomas, Martin Puhr, et al.
Frontiers in Cell and Developmental Biology|December 11, 2025
Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlatesElisabeth Damisch, Elena Brunner, Lukas Nommensen, et al.
Endocrine-Related Cancer|November 28, 2013
SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancerJulia Hoefer, Johann Kern, Philipp Ofer, et al.
Molecular Endocrinology (Baltimore, Md.)|June 9, 2015
miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate CancerLorenza Pasqualini, Huajie Bu, Martin Puhr, et al.
International Journal of Molecular Sciences|September 14, 2024
Prostate Cancer's Silent Partners: Fibroblasts and Their Influence on Glutamine Metabolism ManipulationPia V Hönscheid, Gustavo B Baretton, Martin Puhr, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Endocrinology|September 10, 2024
MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate CancerChiara Andolfi, Caterina Bartolini, Elisa Morales, et al.
Journal of Medicinal Chemistry|December 18, 2024
Eradication of Therapy-Resistant Cancer Stem Cells by Novel Telmisartan DerivativesAnna M Schoepf, Maximilian Gebhart, Martin Federspiel, et al.
Frontiers in Oncology|October 30, 2025
Anti-neoplastic effects of the antipsychotic drug penfluridol in preclinical prostate cancer modelsArjanneke F van de Merbel, Maaike H van der Mark, Tilly Aalders, et al.
The American Journal of Pathology|December 7, 2006
Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancerIlaria Bellezza, Hannes Neuwirt, Constanze Nemes, et al.
International Journal of Molecular Sciences|June 6, 2013
Enhanced inhibition of prostate tumor growth by dual targeting the androgen receptor and the regulatory subunit type iα of protein kinase a in vivoIris E Eder, Martina Egger, Hannes Neuwirt, et al.
Journal of Translational Medicine|January 18, 2024
New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor SymposiumSherif Mehralivand, Christian Thomas, Martin Puhr, et al.
Frontiers in Cell and Developmental Biology|December 11, 2025
Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlatesElisabeth Damisch, Elena Brunner, Lukas Nommensen, et al.
Endocrine-Related Cancer|November 28, 2013
SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancerJulia Hoefer, Johann Kern, Philipp Ofer, et al.
Molecular Endocrinology (Baltimore, Md.)|June 9, 2015
miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate CancerLorenza Pasqualini, Huajie Bu, Martin Puhr, et al.
International Journal of Molecular Sciences|September 14, 2024
Prostate Cancer's Silent Partners: Fibroblasts and Their Influence on Glutamine Metabolism ManipulationPia V Hönscheid, Gustavo B Baretton, Martin Puhr, et al.
Pageof 7